Pharma Journalist -

London – Arena International announced today that the Outsourcing in Clinical Trials Conference (https://arena-international.com/octvirtual/) will be held as a Virtual Experience on…
Read More...

Merck, known as MSD outside the United States and Canada, announced the U.S. launch of ONTRUZANT (trastuzumab-dttb), as a biosimilar of the reference biologic medicine Herceptin.…
Read More...

Applied DNA Sciences Inc. announced that it has completed design qualification, production and shipment of five COVID-19 vaccine candidates to Italy-based Takis Biotech (“Takis”), a…
Read More...

IMMUNOPRECISE ANTIBODIES LTD. announced that it, through its subsidiary Talem Therapeutics, has entered into a research license agreement (the "Agreement") with Janssen Research &…
Read More...

Intensity Therapeutics announced it has entered into a clinical trial collaboration agreement with Bristol Myers Squibb Company. The program will evaluate the safety and efficacy of…
Read More...

Sinovac Biotech Ltd. announced that the Company has obtained approval to conduct a human clinical trial on an inactivated SARS-CoV-2 (commonly referred to as COVID-19) vaccine…
Read More...

PharmaJet, the maker of innovative, needle-free injection technology, announced that its Tropis Needle-free injection system will be used to deliver a COVID-19 vaccine being developed…
Read More...

AstraZeneca will initiate a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm)…
Read More...

Sanofi and GSK announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both…
Read More...

Immunotherapy companies led by Dr. Patrick Soon-Shiong are developing potential coronavirus therapeutics and vaccines to address the evolving stages of disease from moderate infection…
Read More...